Continuation of axitinib for advanced renal cell carcinoma by the application of homecare urology-a case report and literature review

Satoshi Yazawa, Yuji Kato, Jin Nakahara, Toshio Miyata, Mototsugu Oya

Research output: Contribution to journalArticle

Abstract

A 56-year-old man with advanced RCC and a past medical history of type 2 diabetes underwent a radical left nephrectomy following a histological diagnosis of papillary RCC, G2, INF β, pT3, V1 in 1999. In 2008, sorafenib was started to treat multiple pulmonary metastases of RCC. In 2011, sorafenib was switched to sunitinib when radiologic progression was observed. In 2014, sunitinib was switched to axitinib when further radiologic progression was observed. In 2015, the patient was referred to Yazawa clinic for homecare urology when hospital visits became difficult due to cancer pain and bilateral lower-extremity muscle weakness. Cancer pain was controlled using acetaminophen and a fentanyl patch. During the administration of axitinib, a CTCAE grade 1 vocal disorder was detected. We reduced the axitinib dose from 10 mg to 6 mg, and valsartan and an antiflatulent were administered due to CTCAE grade 2 hypertension and diarrhea, respectively. Axitinib administration continued until the patient died. He had survived more than 11 years following the detection of lung metastasis. In this patient, a good balance between cancer treatment and palliative care was achieved through the application of homecare urology. In a super-aged society such as Japan, urologists with an awareness of Zaitaku Medicine, a Japanese style of homecare that provides continuing appropriate medical treatment and welfare support to patients with access barriers to hospital treatment to enable them to live out the remainder of their lives with dignity, may play a key role in the development of Zaitaku Medicine.

Original languageEnglish
Pages (from-to)639-642
Number of pages4
JournalJapanese Journal of Cancer and Chemotherapy
Volume45
Issue number4
Publication statusPublished - 2018 Apr 1

Fingerprint

Urology
Renal Cell Carcinoma
Valsartan
Antifoaming Agents
Medicine
Neoplasm Metastasis
Lung
Muscle Weakness
Fentanyl
Acetaminophen
Nephrectomy
Palliative Care
Type 2 Diabetes Mellitus
Lower Extremity
Diarrhea
Japan
Therapeutics
Hypertension
axitinib
Neoplasms

Keywords

  • Homecare urology
  • Super-aged society
  • Zaitaku (homecare) Medicine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Continuation of axitinib for advanced renal cell carcinoma by the application of homecare urology-a case report and literature review. / Yazawa, Satoshi; Kato, Yuji; Nakahara, Jin; Miyata, Toshio; Oya, Mototsugu.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 45, No. 4, 01.04.2018, p. 639-642.

Research output: Contribution to journalArticle

@article{3e14f79cc3864f63a1eb2c067c0aa1d8,
title = "Continuation of axitinib for advanced renal cell carcinoma by the application of homecare urology-a case report and literature review",
abstract = "A 56-year-old man with advanced RCC and a past medical history of type 2 diabetes underwent a radical left nephrectomy following a histological diagnosis of papillary RCC, G2, INF β, pT3, V1 in 1999. In 2008, sorafenib was started to treat multiple pulmonary metastases of RCC. In 2011, sorafenib was switched to sunitinib when radiologic progression was observed. In 2014, sunitinib was switched to axitinib when further radiologic progression was observed. In 2015, the patient was referred to Yazawa clinic for homecare urology when hospital visits became difficult due to cancer pain and bilateral lower-extremity muscle weakness. Cancer pain was controlled using acetaminophen and a fentanyl patch. During the administration of axitinib, a CTCAE grade 1 vocal disorder was detected. We reduced the axitinib dose from 10 mg to 6 mg, and valsartan and an antiflatulent were administered due to CTCAE grade 2 hypertension and diarrhea, respectively. Axitinib administration continued until the patient died. He had survived more than 11 years following the detection of lung metastasis. In this patient, a good balance between cancer treatment and palliative care was achieved through the application of homecare urology. In a super-aged society such as Japan, urologists with an awareness of Zaitaku Medicine, a Japanese style of homecare that provides continuing appropriate medical treatment and welfare support to patients with access barriers to hospital treatment to enable them to live out the remainder of their lives with dignity, may play a key role in the development of Zaitaku Medicine.",
keywords = "Homecare urology, Super-aged society, Zaitaku (homecare) Medicine",
author = "Satoshi Yazawa and Yuji Kato and Jin Nakahara and Toshio Miyata and Mototsugu Oya",
year = "2018",
month = "4",
day = "1",
language = "English",
volume = "45",
pages = "639--642",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "4",

}

TY - JOUR

T1 - Continuation of axitinib for advanced renal cell carcinoma by the application of homecare urology-a case report and literature review

AU - Yazawa, Satoshi

AU - Kato, Yuji

AU - Nakahara, Jin

AU - Miyata, Toshio

AU - Oya, Mototsugu

PY - 2018/4/1

Y1 - 2018/4/1

N2 - A 56-year-old man with advanced RCC and a past medical history of type 2 diabetes underwent a radical left nephrectomy following a histological diagnosis of papillary RCC, G2, INF β, pT3, V1 in 1999. In 2008, sorafenib was started to treat multiple pulmonary metastases of RCC. In 2011, sorafenib was switched to sunitinib when radiologic progression was observed. In 2014, sunitinib was switched to axitinib when further radiologic progression was observed. In 2015, the patient was referred to Yazawa clinic for homecare urology when hospital visits became difficult due to cancer pain and bilateral lower-extremity muscle weakness. Cancer pain was controlled using acetaminophen and a fentanyl patch. During the administration of axitinib, a CTCAE grade 1 vocal disorder was detected. We reduced the axitinib dose from 10 mg to 6 mg, and valsartan and an antiflatulent were administered due to CTCAE grade 2 hypertension and diarrhea, respectively. Axitinib administration continued until the patient died. He had survived more than 11 years following the detection of lung metastasis. In this patient, a good balance between cancer treatment and palliative care was achieved through the application of homecare urology. In a super-aged society such as Japan, urologists with an awareness of Zaitaku Medicine, a Japanese style of homecare that provides continuing appropriate medical treatment and welfare support to patients with access barriers to hospital treatment to enable them to live out the remainder of their lives with dignity, may play a key role in the development of Zaitaku Medicine.

AB - A 56-year-old man with advanced RCC and a past medical history of type 2 diabetes underwent a radical left nephrectomy following a histological diagnosis of papillary RCC, G2, INF β, pT3, V1 in 1999. In 2008, sorafenib was started to treat multiple pulmonary metastases of RCC. In 2011, sorafenib was switched to sunitinib when radiologic progression was observed. In 2014, sunitinib was switched to axitinib when further radiologic progression was observed. In 2015, the patient was referred to Yazawa clinic for homecare urology when hospital visits became difficult due to cancer pain and bilateral lower-extremity muscle weakness. Cancer pain was controlled using acetaminophen and a fentanyl patch. During the administration of axitinib, a CTCAE grade 1 vocal disorder was detected. We reduced the axitinib dose from 10 mg to 6 mg, and valsartan and an antiflatulent were administered due to CTCAE grade 2 hypertension and diarrhea, respectively. Axitinib administration continued until the patient died. He had survived more than 11 years following the detection of lung metastasis. In this patient, a good balance between cancer treatment and palliative care was achieved through the application of homecare urology. In a super-aged society such as Japan, urologists with an awareness of Zaitaku Medicine, a Japanese style of homecare that provides continuing appropriate medical treatment and welfare support to patients with access barriers to hospital treatment to enable them to live out the remainder of their lives with dignity, may play a key role in the development of Zaitaku Medicine.

KW - Homecare urology

KW - Super-aged society

KW - Zaitaku (homecare) Medicine

UR - http://www.scopus.com/inward/record.url?scp=85049401145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049401145&partnerID=8YFLogxK

M3 - Article

C2 - 29650821

AN - SCOPUS:85049401145

VL - 45

SP - 639

EP - 642

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 4

ER -